REC: Interventional Cardiology (English Ed.) (May 2020)

Time trend in transcatheter aortic valve implantation: an analysis of the Spanish TAVI registry

  • Pilar Jiménez-Quevedo,
  • Antonio Muñoz-García,
  • Ramiro Trillo-Nouche,
  • Raquel del Valle,
  • José María de la Torre Hernández,
  • Luisa Salido,
  • Enrique Gutiérrez,
  • Manuel Pan,
  • Joaquín Sánchez-Gila,
  • Bruno García del Blanco,
  • Raúl Moreno,
  • Roberto Blanco Mata,
  • Juan Francisco Oteo,
  • Ignacio Amat-Santos,
  • Ander Regueiro,
  • Francisco Ten,
  • Juan Manuel Nogales,
  • Eduard Fernández-Nofrerias,
  • Leire Andraka,
  • María Cruz Ferrer,
  • Eduardo Pinar,
  • Rafael Romaguera,
  • Carlos Cuellas Ramón,
  • Fernando Alfonso,
  • Sergio García-Blas,
  • Antonio Piñero,
  • Julia Ignasi,
  • Rocío Díaz Méndez,
  • Pascual Bordes,
  • Juan Meseguer,
  • Luis Nombela-Franco

DOI
https://doi.org/10.24875/RECICE.M20000104
Journal volume & issue
Vol. 2, no. 2
pp. 98 – 105

Abstract

Read online

ABSTRACT Introduction and objectives: This study primary endpoint was to present the in-hospital all-cause mortality of the Spanish TAVI registry from its inception until 2018. Secondary endpoints included other in-hospital clinical events, 30-day all-cause mortality, and an assessment of the time trend of this registry. Methods: All consecutive patients included in the Spanish TAVI registry were analyzed. In this time-based analysis, the population was been divided into patients treated before 2014 (cohort A: 2009-2013) and patients treated between 2014 and 2018 (cohort B). Results: From August 2007 to June 2018, 7180 patients were included. The mean age was 81.2 ± 6.5 years and 53% were women. The logistic EuroSCORE was 12% (8-20). Transfemoral access was used in 89%. In-hospital and 30-day all-cause mortality was 4.7% and 5.7%, respectively. On the time-based analyses during the hospital stay, the rate of myocardial infarction, stroke, need for pacemakers, tamponade, coronary obstruction, and vascular complications was similar between both groups. However, cohort B showed less need for conversion to surgery and malapposition of the valve. Also, the implant success rate increased from 93% to 96% (P< .001). In-hospital and 30-day all-cause mortality was significantly lower in cohort B, ([OR, 0.65; IC95%, 0.48-0.86; P= .003] and [OR, 0.71; IC95%, 0.54-0.92; P= .002], respectively). Conclusions: The time trend analysis of the Spanish TAVI registry showed a change in the patients’ clinical profile and an improvement in the in-hospital clinical outcomes and 30-day all-cause mortality in patients treated more recently.

Keywords